S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
Log in
ASX:LSH

Lifespot Health Ltd (LSH.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume120,633 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Lifespot Health Ltd, together with its subsidiaries, focuses on the development and commercialization of medical diagnostic and monitoring technology solutions in Australia and Germany. The company is developing the BodyTel System that integrates multiple sensors for capturing diagnostic information for additional diseases; and Seng-Vital, a digitally integrated cannabis vaporizer system. Lifespot Health Ltd is based in Melbourne, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.52 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolASX:LSH
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.lifespot-health.com
Phone61 3 9191 0135
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current Ratio2.82
Quick Ratio2.58

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$43,975.00
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow2.71
Book ValueA$0.01 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive LSH News and Ratings via Email

Sign-up to receive the latest news and ratings for LSH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lifespot Health Ltd (LSH.AX) (ASX:LSH) Frequently Asked Questions

What stocks does MarketBeat like better than Lifespot Health Ltd (LSH.AX)?

Wall Street analysts have given Lifespot Health Ltd (LSH.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lifespot Health Ltd (LSH.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Lifespot Health Ltd (LSH.AX)'s key competitors?

Some companies that are related to Lifespot Health Ltd (LSH.AX) include (BUX) (BUX), 12144 (IME), BARD1 Life Sciences Limited (BD1.AX) (BD1), Charles River Laboratories International (CRL), Cryosite Limited (CTE.AX) (CTE), dorsaVi Ltd (DVL.AX) (DVL), Epigenomics (EPGNY), Eternity Healthcare (ETAH), Genetic Signatures Limited (GSS.AX) (GSS), Genetic Technologies Limited (GTG.AX) (GTG), Imagion Biosystems Limited (IBX.AX) (IBX), Integral Diagnostics Limited (IDX.AX) (IDX), Medical Imaging (MEDD), OncoSil Medical Limited (OSL.AX) (OSL) and Parallax Health Sciences (PRLX).
View all competitors.

Who are Lifespot Health Ltd (LSH.AX)'s key executives?

Lifespot Health Ltd (LSH.AX)'s management team includes the following people:
  • Mr. Matthew Golden, Chief Exec. Officer
  • Mr. Justyn Peter Stedwell B.Com., B.Com, Company Sec. & Non-Exec. Director

What is Lifespot Health Ltd (LSH.AX)'s stock symbol?

Lifespot Health Ltd (LSH.AX) trades on the ASX under the ticker symbol "LSH."

How big of a company is Lifespot Health Ltd (LSH.AX)?

Lifespot Health Ltd (LSH.AX) has a market capitalization of $0.00 and generates $43,975.00 in revenue each year.

What is Lifespot Health Ltd (LSH.AX)'s official website?

The official website for Lifespot Health Ltd (LSH.AX) is www.lifespot-health.com.

How can I contact Lifespot Health Ltd (LSH.AX)?

The company can be reached via phone at 61 3 9191 0135.

This page was last updated on 11/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.